Continuing Medical Education: Hepatology CME: 2010 National Hepatitis B&C Training Program & Treatment Update: Scripps Clinic: Los Angeles, CA: September 11, 2010
http://www.cmenetworks.com/cme/11530/1/Continuing-Medical-Education-Hepatology-CME-2010-National-Hepatitis-BampC-Training-Program-amp-Treatment-Update-Scripps-Clinic-Los-Angeles-CA-September-11-2010/Page1.html
Scripps Health
Scripps Health is a $1.7 billion, non-profit, community-based health care system in San Diego, Calif. Scripps treats nearly 500,000 patients annually through the dedication of more than 2,600 affiliated physicians and 11,000 employees across five hospital campuses, an ambulatory care network of clinics, physicians’ offices, outpatient centers and home health care services.
By Scripps Health
Published on 04/16/2010
CME Sponsor:
Scripps Clinic
Location:
Hilton Los Angeles/San Gabriel
225 West Valley Blvd.
San Gabriel, CA 91776
626-270-2700
Course Director:
Sammy Saab, MD
University of California, Los Angeles
Tse-Ling Fong, MD
University of Southern California
Mary Peralta Sr., LVN
University of California, Los Angeles
Number of Credits:
7.75 AMA PRA Category 1 Credits™
Registration Fee:
Hepatitis C Morning Session: Pre-Registration - $45; On-site Registration - $55
Hepatitis B Afternoon Session: Pre-Registration - $45; On-site Registration $55
Hepatitis C and B: Pre-Registration - $75; On-site Registration - $90
More Info
Detailed Description:
A new IOM study entitled Hepatitis and Liver Cancer: A National Strategy forPrevention and Control of Hepatitis B and C finds that despite the prevalence of the diseases, they are not widely recognized as serious public health problems and states: “An estimated 0.8–1.4 million people in the United States are chronically infected with hepatitis B virus (HBV) and 2.7–3.9 million people are chronically infected with hepatitis C virus (HCV). Lack of awareness about the prevalence of chronic viralhepatitis in the United States and about the proper methods and target populations for screening and medical management of chronic hepatitis B and hepatitis C contributes to continuing transmission; missing of opportunities for prevention, including vaccination; missing of opportunities for early diagnosis and medical care; and poor health outcomes in infected people.”
The Scripps National Hepatitis B & C Training Program and Treatment Update will contribute towards increasing the number of health care practitioners educated on the prevalence of chronic viral hepatitis, as well as those properly preventing, diagnosing, treating, and/or referring patients with chronic illness; therefore contributing towards prevention of new cases and improved management of already infected patients.
Learning Objectives:
• Discuss the prevalence and incidence of acute and chronic hepatitis B and hepatitis C both in the general US population and in at-risk populations.
• Review the history, epidemiology, demographics, natural history, histology, immunology and patho physiology of the viral infection.
• Discuss state-of-the-art diagnostic and treatment guidelines for both hepatitis B and C.
• Formulate and/or implement strategies for preventing, diagnosing, treating, and/or referring patients with HBV and/or HCV.
• Evaluate the multidisciplinary team approach to care of patients with hepatitis B and C.
• Establish a local network of practitioners for information sharing, referrals, etc.
• Improve the health of patients infected with the HBV and/or HCV virus.
Intended Audience:
• Family Practice Physicians
• Gastroenterologists
• Hepatologists
• Internists
• Infectious Disease Specialists
• OB/GYN physicians
• Pediatricians
• Nurses
• Physician Assistants
2010 National Hepatitis B&C Training Program & Treatment Update
CME Sponsor:
Scripps Clinic
Location:
Hilton Los Angeles/San Gabriel
225 West Valley Blvd.
San Gabriel, CA 91776
626-270-2700
Course Director:
Sammy Saab, MD
University of California, Los Angeles
Tse-Ling Fong, MD
University of Southern California
Mary Peralta Sr., LVN
University of California, Los Angeles
Number of Credits:
7.75 AMA PRA Category 1 Credits™
Registration Fee:
Hepatitis C Morning Session: Pre-Registration - $45; On-site Registration - $55
Hepatitis B Afternoon Session: Pre-Registration - $45; On-site Registration $55
Hepatitis C and B: Pre-Registration - $75; On-site Registration - $90
More Info
Detailed Description:
A new IOM study entitled Hepatitis and Liver Cancer: A National Strategy forPrevention and Control of Hepatitis B and C finds that despite the prevalence of the diseases, they are not widely recognized as serious public health problems and states: “An estimated 0.8–1.4 million people in the United States are chronically infected with hepatitis B virus (HBV) and 2.7–3.9 million people are chronically infected with hepatitis C virus (HCV). Lack of awareness about the prevalence of chronic viralhepatitis in the United States and about the proper methods and target populations for screening and medical management of chronic hepatitis B and hepatitis C contributes to continuing transmission; missing of opportunities for prevention, including vaccination; missing of opportunities for early diagnosis and medical care; and poor health outcomes in infected people.”
The Scripps National Hepatitis B & C Training Program and Treatment Update will contribute towards increasing the number of health care practitioners educated on the prevalence of chronic viral hepatitis, as well as those properly preventing, diagnosing, treating, and/or referring patients with chronic illness; therefore contributing towards prevention of new cases and improved management of already infected patients.
Learning Objectives:
• Discuss the prevalence and incidence of acute and chronic hepatitis B and hepatitis C both in the general US population and in at-risk populations.
• Review the history, epidemiology, demographics, natural history, histology, immunology and patho physiology of the viral infection.
• Discuss state-of-the-art diagnostic and treatment guidelines for both hepatitis B and C.
• Formulate and/or implement strategies for preventing, diagnosing, treating, and/or referring patients with HBV and/or HCV.
• Evaluate the multidisciplinary team approach to care of patients with hepatitis B and C.
• Establish a local network of practitioners for information sharing, referrals, etc.
• Improve the health of patients infected with the HBV and/or HCV virus.
Intended Audience:
• Family Practice Physicians
• Gastroenterologists
• Hepatologists
• Internists
• Infectious Disease Specialists
• OB/GYN physicians
• Pediatricians
• Nurses
• Physician Assistants